Correlation of Diabetes Control with Benign Prostatic Hyperplasia in T2DM Patients
褚琳,陈陵霞,苗懿德,刘杰,宝辉,魏雅楠,郏蓉,苏琳,张庆文,李卫
DOI: https://doi.org/10.3969/j.issn.1007-9572.2013.23.003
2013-01-01
Chinese General Practice
Abstract:Objective To evaluate the relationship between diabetes control and benign prostatic hyperplasia(BPH) in type 2 diabetes mellitus(T2DM).Methods Totally 154 male T2DM patients were divided into groups A(control group,n = 67),B(blood glucose controlled to standard,n = 46),C(blood glucose controlled not to standard,n = 41).Blood pressure,body weight,body height were measured,body mass index(BMI) calculated,levels of serum fast glucose(FPG),total cholesterol(TC),triglycerides(TG),low-density lipoprotein cholesterol(LDL-C),high-density lipoprotein cholesterol(HDL-C),glycosylated hemoglobin(HbA1c) and prostate-specific antigen(PSA) detected.Total prostate volume(PV) were measured by ultrasound.Results PV increased significantly in group C as compared with groups A and B(q =-3.02,-2.00,P 0.05);Annual PV growth rate was significantly higher in group C than in groups A,B(q =-3.19,-2.48,P 0.05);By Pearson correlation analysis,PV was positively correlated with HbA1c,FPG,PSA(r = 0.260,0.195,0.363,P 0.05),negatively with HDL-C(r =-0.192,P 0.05);Annual PV growth rate was positively correlated with HbA1c,FPG,LDL-C and PSA(r =0.272,0.219,0.164,0.348,P 0.05),negatively with HDL-C(r = 0.216,P 0.05).Conclusion Well controlling blood glucose can slow down effectively the growth rate of PV and delay BPH progression.
What problem does this paper attempt to address?